These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 15126917

  • 1. Chronic l-arginine treatment reduces vascular smooth muscle cell hypertrophy through cell cycle modifications in spontaneously hypertensive rats.
    Somoza B, González C, Cachofeiro V, Lahera V, Fernández-Alfonso MS.
    J Hypertens; 2004 Apr; 22(4):751-8. PubMed ID: 15126917
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide and vascular hypertrophy.
    Stauss HM.
    J Hypertens; 2004 Apr; 22(4):677-8. PubMed ID: 15126903
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nitric oxide synthase induction by ouabain in vascular smooth muscle cells from normotensive and hypertensive rats.
    Pacheco ME, Marín J, Manso AM, Rodríguez-Martínez MA, Briones A, Salaices M, Redondo J.
    J Hypertens; 2000 Jul; 18(7):877-84. PubMed ID: 10930185
    [Abstract] [Full Text] [Related]

  • 5. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension.
    Boulanger CM, Heymes C, Benessiano J, Geske RS, Lévy BI, Vanhoutte PM.
    Circ Res; 2000 Jul; 83(12):1271-8. PubMed ID: 9851944
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of inducible type nitric oxide synthase against intracellular oxidative stress caused by advanced glycation end-products in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
    Mizutani K, Ikeda K, Ito T, Tamaki K, Nara Y, Yamori Y.
    J Hypertens; 2000 Aug; 18(8):1071-9. PubMed ID: 10953999
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
    Beasley D, McGuiggin M.
    J Exp Med; 1994 Jan 01; 179(1):71-80. PubMed ID: 7505803
    [Abstract] [Full Text] [Related]

  • 8. Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats.
    Bravo R, Somoza B, Ruiz-Gayo M, González C, Ruilope LM, Fernández-Alfonso MS.
    Hypertension; 2001 May 01; 37(5):E4-E10. PubMed ID: 11358952
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
    Beasley D, Schwartz JH, Brenner BM.
    J Clin Invest; 1991 Feb 01; 87(2):602-8. PubMed ID: 1671393
    [Abstract] [Full Text] [Related]

  • 10. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate.
    Kibbe MR, Li J, Nie S, Watkins SC, Lizonova A, Kovesdi I, Simmons RL, Billiar TR, Tzeng E.
    J Vasc Surg; 2000 Jun 01; 31(6):1214-28. PubMed ID: 10842159
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Altered insulin-like growth factor-1 and nitric oxide sensitivities in hypertension contribute to vascular hyperplasia.
    Nolan BP, Senechal P, Waqar S, Myers J, Standley CA, Standley PR.
    Am J Hypertens; 2003 May 01; 16(5 Pt 1):393-400. PubMed ID: 12745202
    [Abstract] [Full Text] [Related]

  • 13. Amlodipine and vascular hypertrophy.
    Stepien O, Iouzalen L, Herembert T, Zhu DL, Marche P.
    Int J Cardiol; 1997 Dec 31; 62 Suppl 2():S79-84. PubMed ID: 9488198
    [Abstract] [Full Text] [Related]

  • 14. Evidence for inducible nitric oxide synthase in spontaneously hypertensive rats.
    Wu CC, Hong HJ, Chou TC, Ding YA, Yen MH.
    Biochem Biophys Res Commun; 1996 Nov 12; 228(2):459-66. PubMed ID: 8920935
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation.
    Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Lüscher TF.
    Circulation; 2000 Apr 25; 101(16):1982-9. PubMed ID: 10779466
    [Abstract] [Full Text] [Related]

  • 16. Changes of inducible nitric oxide synthase in aortic cells during the development of hypertension: effect of angiotensin II.
    Cruzado M, Castro C, Risler N, Miatello R.
    Biocell; 2002 Apr 25; 26(1):61-7. PubMed ID: 12058382
    [Abstract] [Full Text] [Related]

  • 17. Proteoglycans production by aortic vascular smooth muscle cells from hypertensive rats.
    Risler N, Castro C, Cruzado M, González S, Miatello R.
    Biocell; 2003 Aug 25; 27(2):189-96. PubMed ID: 14510237
    [Abstract] [Full Text] [Related]

  • 18. Different cell cycle regulation of vascular smooth muscle in genetic hypertension.
    Tanner FC, Greutert H, Barandier C, Frischknecht K, Lüscher TF.
    Hypertension; 2003 Aug 25; 42(2):184-8. PubMed ID: 12847112
    [Abstract] [Full Text] [Related]

  • 19. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells.
    Kusano E, Tian S, Umino T, Tetsuka T, Ando Y, Asano Y.
    J Hypertens; 1997 Jun 25; 15(6):627-32. PubMed ID: 9218182
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA.
    Br J Pharmacol; 1997 May 25; 121(1):125-33. PubMed ID: 9146896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.